Jeff Smith

Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)

Messoud Ashina, Joel R. Saper, Roger Cady et al. · Cephalalgia · 2020 · 375 citations · Full text

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

David W. Dodick, Peter J. Goadsby, Stephen D. Silberstein et al. · The Lancet Neurology · 2014 · 369 citations

Gene-related Peptide, Cluster Headache, Frequent Episodic Migraine +6

Efficacy and safety of eptinezumab in patients with chronic migraine

Richard B. Lipton, Peter J. Goadsby, Jeff Smith et al. · Neurology · 2020 · 368 citations · Full text

Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial

David W. Dodick, Richard B. Lipton, Stephen D. Silberstein et al. · Cephalalgia · 2019 · 153 citations

Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine

Chuka Nwokolo, Jeff Smith, C. J. Gavey et al. · Alimentary Pharmacology & Therapeutics · 1990 · 149 citations